SavedAdd your journal

Journals / Göztepe Tıp Dergisi / 2009 / Cilt: 24 - Sayı: 4

Osteoporosis in rheumatoid arthritis

Romatoid artritte osteoporoz

Yasemin YUMUŞAKHUYLU
Afitap İÇAĞASIOĞLU
Şirin Rafiye ALTIĞ
Bilir Başak KAYA
Moral Füsun OĞUZ
Sema HALİLOĞLU
Şule Hatice BAKLACIOĞLU
Pages
159–163
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RA duration and decrease in femur neck BMD was found statistically meaningful (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Osteoporosis (OP) is known as a major comorbidity in rheumatoid arthritis (RA) patients.
📊
Key Findings & Data:Materials and Methods: 54 female patient, who were attended to rheumatology outpatient clinic in Göztepe Education and Research Hospital and diagnosed as RA according to ACR criteria, were included in the research.
💡
Conclusion & Impact:RA duration and decrease in femur neck BMD was found statistically meaningful (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Osteoporosis (OP) is known as a major comorbidity in rheumatoid arthritis (RA) patients. Aim of this study is to evaluate OP and risk factors of OP in RA patients. Materials and Methods: 54 female patient, who were attended to rheumatology outpatient clinic in Göztepe Education and Research Hospital and diagnosed as RA according to ACR criteria, were included in the research. Study was designed as a retrospective research. Patients were evaluated according to demographic data, received therapy, duration of RA, menopause status, fracture history, disease activity score-DAS 28, health assessment questionnaire (HAQ) score, lumbar AP and femur neck DXA measurements.Results: Mean age of patients was 52.72 (39-67) years, RA duration was 10.20 (1-30) years. DAS 28 scores, received therapy, RA duration, menopause status and HAQ scores were compared with bone mineral density (BMD). RA duration and decrease in femur neck BMD was found statistically meaningful (p

Özet

Amaç: Romatoid Artritli (RA) hastalarda osteoporoz (OP) major komorbidite olarak tanınmaktadır. Bu çalışmanın amacı RA’lı hastalarda OP ve OP risk faktörlerini araştırmaktır.Gereç ve Yöntem: Çalışmaya Göztepe Eğitim Araştırma Hastanesi, Romatoloji polikliniğine başvuran, daha önce ACR kriterelerine göre RA tanısı almış olan 54 kadın hasta alındı. Hastalar retrospektif olarak değerlendirildi. Hastalar, demografik özellikleri, aldıkları tedaviler, RA süreleri, menopoz durumları, kırık hikayeleri, hastalık aktiviteleri (disease activity score-DAS 28), Health Assessment Questionnaire (HAQ) skorları ve lomber AP ve femur boynu DXA ölçümleri yönünden incelendi. Bulgular: Hastaların yaş ortalaması 52.72 (39-67), RA süreleri ortalama 10.20 (1-30) yıl idi. DAS 28 skorları, ilaç kullanımları, RA süreleri, menopoz durumları ve HAQ skorları ile kemik mineral yoğunluğu (KMY) ölçümleri karşılastırıldı. RA süresi ile femur boynu KMY’ndaki düşüklük anlamlı olarak ilişkili bulundu (p

🔖

Cite This Article

YUMUŞAKHUYLU, Y., İÇAĞASIOĞLU, A., ALTIĞ, Ş. R., KAYA, B. B., OĞUZ, M. F., HALİLOĞLU, S., BAKLACIOĞLU, Ş. H. (2022). Osteoporosis in rheumatoid arthritis. Göztepe Tıp Dergisi, Cilt: 24 - Sayı: 4, 159–163. https://ajindex.com/articles/526218

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Gümüşdiş G, Doğanavşargil E. Klinik Romatoloji, Romatoid Artrit 269-278
  2. Sinigaglia L, Varenna M, Girasole G, et al.Epidemiology of Osteoporosis in Rheumatic Diseases. Rheum Dis Clin N Am 2006;32:631-658
  3. TP Van Staa, P Geusens, JWJ Bijisma, et al. Clinical assesment of the long term risk of fractures in patients with rheumatoid arthritis. Arthritis Rheum 2006;54(10):3104-12
  4. Michel BA, Bloch DA, Wolfe F, et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20(10):1666-9
  5. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54(1):49-52
  6. Kaz Kaz H, Johnson D, Kerry S, et al. Fall-related risk factors and osteoporosis in women with rheumatoid arthritis. Rheumatology (Oxford) 2004;43(10):1267-71
  7. R F Laan, P L van Riel, and L B van de Putte: Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51(6):826-832
  8. Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman Y P M, et al. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis 2007;66:1508-1512
  9. Sarıkaya S, Özdolap Ş, Tekin İ Ö, ve ark. Romatoid Artritte Romatoid Faktör, Fonksiyonel Durum ve Hastalık Aktivitesinin Kemik Kaybı Üzerine Etkisi. Türkiye Fiziksel Tıp Ve Rehabilitasyon Dergisi 51(4), 2005
  10. Haugeberg G, Uhlig T, Falch J A, et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County rheumatoid arthritis register. Arthritis Rheum 2000;43(3):522-30
  11. Haugeberg G, Orstavik RE, Uhlig T, et al. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46(7):1720-8
  12. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996;35(4):309-22
  13. Martin JC, Munro R, campbell MK, et al. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997;36(1):43-9
  14. Suzuki Y, Mizushima Y. Osteoporosis in rheumatoid arthritis. Osteoporos Int 1997;7(3):217-22
  15. Sinigaglia L, Nervetti A, Mela Q, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000;27(11